Product NDC: | 25021-658 |
Proprietary Name: | Vecuronium |
Non Proprietary Name: | vecuronium bromide |
Active Ingredient(s): | 20 mg/20mL & nbsp; vecuronium bromide |
Administration Route(s): | INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 25021-658 |
Labeler Name: | Sagent Pharmaceuticals |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA078274 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110801 |
Package NDC: | 25021-658-20 |
Package Description: | 10 VIAL in 1 CARTON (25021-658-20) > 20 mL in 1 VIAL |
NDC Code | 25021-658-20 |
Proprietary Name | Vecuronium |
Package Description | 10 VIAL in 1 CARTON (25021-658-20) > 20 mL in 1 VIAL |
Product NDC | 25021-658 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | vecuronium bromide |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAVENOUS |
Start Marketing Date | 20110801 |
Marketing Category Name | ANDA |
Labeler Name | Sagent Pharmaceuticals |
Substance Name | VECURONIUM BROMIDE |
Strength Number | 20 |
Strength Unit | mg/20mL |
Pharmaceutical Classes | Neuromuscular Nondepolarizing Blockade [PE],Nondepolarizing Neuromuscular Blocker [EPC] |